Who We Are

Susanti

Susanti

CEO/ Director

Santi is a trained pharmacist graduated from Universitas Gadjah Mada, an entrepreneur in community pharmacy, a lecturer and a researcher in the field of pharmacology, cancer biology, genetics and molecular pathology. She combined her scientific expertise with her personal experience as cancer survivor to found PathGen Diagnostik Teknologi, a start-up which focuses on utilising low-cost technology for molecular genotyping to guide the care of cancer (and other diseases) in resource-limited countries like Indonesia.

She obtained a M.Phil (Master of Philosophy) from The John Curtin School of Medical Research at the Australian National University. She is currently finishing her PhD and now a research fellow in Molecular Pathology Group, School of Medicine, University of Nottingham and a lecturer at Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto.

Together with her supervisor in Nottingham, Professor Mohammad Ilyas, she established an initiative called NICCRAT (Nottingham-Indonesia Collaboration for Clinical Research and Training) to foster partnership in research and capacity building with various institution in Indonesia, including Indonesian Institute of Science (Lembaga Ilmu Pengetahuan Indonesia/LIPI), Stem Cell and Cancer Institute of Kalbe Farma, Tbk and several medical schools such as in Univeristas Gadjah Mada, Universitas Yarsi, and Muhammadiyah University network.

Astrid Unggul Pawestri

Astrid Unggul Pawestri

Commissioner

Astrid is a law graduate from Universitas Gadjah Mada. She pursued a master degree in supply chain management at Erasmus University of Rotterdam. She is certified legal auditor by ASAHI (Asosiasi Auditor Hukum Indonesia/ Indonesia Association for Legal Auditors) and member of PERADI (Perhimpuan Advokat Indonesia/ Indonesia Advocates Association). She is now working as senior counsel of legal and regulatory compliance at a state owned company which engages in port related business.

Prof. Mohammad Ilyas, FRCPath

Prof. Mohammad Ilyas, FRCPath

Principal, Scientific Advisor

Professor Ilyas is Professor of Pathology at the University of Nottingham. His research encompasses both basic science and translational research. His areas of interest include the molecular pathology of cancer (especially the roles of Wnt signalling, CD24 and TNS4 in tumourigenesis), liquid biopsy testing for cancer surveillance and digital pathology. Together with his former PhD student, Ms. Susanti, he initiated the NICCRAT (Nottingham-Indonesia collaboration for Clinical Research and Training) initiative to promote the partnership between researchers in the UK and Indonesia

He obtained his medical degree from Bristol University. He subsequently trained as a histopathologist with a specialist interest in gastrointestinal pathology. He undertook a PhD investigating the genetic basis of colorectal cancer at Oxford University in Sir Walter Bodmers lab. He continued this work as an MRC (Medical Research Council) Clinician Scientist prior to his appointment as professor at University of Nottingham in 2005.

Dr. Wien Kusharyoto

Dr. Wien Kusharyoto

Scientific Advisor

Dr Wien is a Head of Laboratory of Applied Genetic Engineering and Protein Design, Research Center for Biotechnology – Indonesian Institute of Sciences (LIPI). His expertise includes structural bioinformatics (protein modelling, docking and molecular dynamics simulation), protein engineering (molecular cloning and protein expression in E. coli and P. pastoris protein modification, protein chromatography), and molecular diagnostics (multiplex PCR, nucleic acid lateral flow assay).

He did his graduate and postgraduate study in Germany where He obtained his B.Sc. and M.Sc. (Dipl.-Chem. Certificate) from Technical University Braunschweig and his PhD (Dr. rer. nat. Certificate) from University Stuttgart.

Dr. Ahmad Utomo

Dr. Ahmad Utomo

Scientific Advisor

Dr. Ahmad is a principal investigator in Stem Cell and Cancer Institute of Kalbe Farma, Tbk and a laboratory consultant in Kalbe Genomics (Kalgen). His works mainly focus on developing and validating cost-effective molecular genetic testing platform in tumour genotyping to support personalized medicine.

He did his PhD in molecular medicine at University of Texas Health Science Center, San Antonio, developing transgenic mice model of human breast cancer by spatial and temporal inactivation of BRCA1 gene using cre-recombinase. He spent about 4 years at Harvard Medical School as senior American Lung Association research fellow at Department of Pathology of Brigham and Womens Hospital, studying the mechanism of inflammatory lung injury in Dr Tanya Mayadas laboratory.

Prof. DR. Dr. Aru W. Sudoyo, Sp.PD, KHOM, FINASIM, FACP

Prof. DR. Dr. Aru W. Sudoyo, Sp.PD, KHOM, FINASIM, FACP

Scientific Advisor

Professor Aru is a leading oncologist in Indonesia and senior staff at Division of Hematology and Medical Oncology, Department of Internal Medicine, Universitas Indonesia. He also currently is the chair of Indonesia Cancer Foundation (Yayasan Kanker Indonesia/YKI) and The Indonesian Society for Oncology. He was among the first to publish the work about the higher frequency of young colorectal cancer (CRC) patients in Indonesia. His recent research involves the study of molecular marker of CRC.

Prof. Ian Tomlinson

Prof. Ian Tomlinson

Scientific Advisor

Professor Tomlinson is a professor of molecular and population genetics at the University of Edinburgh and currently the Director of Edinburgh Cancer Research Centre (including Cancer Research UK Edinburgh Centre). He was previously Director of the Institute of Cancer and Genomic Sciences at the University of Birmingham, having worked before that at the Cancer Research UK London Research Institute, University of Oxford and the Institute of Cancer Research.

His research interests lie in discovering and functionally characterising cancer driver genes, especially germline variants that predispose to cancer. He also has a longstanding interest in cancer evolution, derived from his PhD project in population genetics, with a specific interest in the relative contributions of selection and mutation to cancer growth.

Ahmad Yunarto

Ahmad Yunarto

Business and Development Advisor

Mr. Ahmad is the founder and chairman of Biru Peduli Foundation, a non-profit organization focusing on community empowerment in Indonesia. With his engineering background he spent 22.5 years in working at international oilfield company, Schlumberger, where he reached the position of Chairman of Schlumberger Indonesia before he decided to voluntary step down to focus more on his charity and executive coach works.

Accomplished Indonesian professional with extensive international exposure and diverse leadership and managerial experiences, he is passionate on people development, mentoring, coaching and social investment. Ahmad is active as Senior Advisor to Boston Consulting Group, Shell Upstream Indonesia, Badan Meteorologi dan Geofisika, and New Zealand Trade and Enterprise, and Indonesia Geothermal Association. Ahmad also serves as the Chair of Board of Patron Save the Children Indonesia, Board of Advisor for Electrical Engineering Department, Universitas Gadjah Mada, Board of Patron Nusantara Innovation Forum.

He is a professional-lecturer at School of Business Management ITB. He graduated from Universitas Gadjah Mada majoring in electrical engineering and completed his postgraduate study in organizational leadership at Said Business School, University of Oxford.

Asep M. Ridwanuloh

Asep M. Ridwanuloh

Chief of Science

Asep is researcher at the Research Center for Biotechnology, Indonesian Institute of Science (Lembaga Ilmu Pengetahuan Indonesia/LIPI). He has gained experience in how to synthesize some compounds as a drug candidate to inhibit tumour cells, and in the last five years he has developed some nucleotide-based methods for cancer detection. He was awarded research grants from The Ministry of Research, Technology and Higher Education of Indonesia, International Toray Science Foundation and Indonesian Institute of Sciences. He has collaborated with hospitals, universities and private companies in Indonesia.

He is a member of the International Association for Study of Lung Cancer. He graduated for Universitas Jenderal Soedirman in Purwokerto majoring chemistry and obtained his masters degree in biotechnology in Institute Pertanian Bogor.

Satrio Wibowo

Satrio Wibowo

Research Associate

Satrio is a young scientist currently working primarily in PathGen Diagnostik Teknologi doing the day to day research and development for the company. He has previous experience working in molecular biology-based research projects including genetic profiling of cancer stem cells and pilot GMP production of mesenchymal stem cells for cell-based therapy. Satrio is graduated from Universitas Pendidikan Indonesia majoring biology. He also has experience working in health-related start-up company.

Gilang Akbariani

Gilang Akbariani

Research Associate

Gilang is young scientist with degree in Pharmacy from Universitas Muhammadiyah Purwokerto. Gilang is one of the researchers who is working primarily in PathGen Diagnostik Teknologi doing the day to day research and development for the company. She obtained her masters degree from Institute of Biomedical Materials and Tissue Engineering, Taipei Medical University. She has vast experience in nanoparticle formulation of medicinal plant active compounds for cancer and anti-inflammatory agents.